We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
SILDENAFIL-ISPL, SILCAP, SILDENACAP (iX Biopharma Pty Ltd)
Product name
SILDENAFIL-ISPL, SILCAP, SILDENACAP
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
183 working days (255)
Active ingredients
Sildenafil citrate
Registration type
New generic medicine
Indication
SILDENAFIL-ISPL, SILCAP, SILDENACAP (capsules) is indicated for the treatment of erectile dysfunction in adult males. Sildenafil is not indicated for use by women.